Published in J Neurovirol on September 01, 2009
HIV-1 gp120 and drugs of abuse: interactions in the central nervous system. Curr HIV Res (2012) 0.98
HIV gp120- and methamphetamine-mediated oxidative stress induces astrocyte apoptosis via cytochrome P450 2E1. Cell Death Dis (2013) 0.96
HIV-1 Tat protein decreases dopamine transporter cell surface expression and vesicular monoamine transporter-2 function in rat striatal synaptosomes. J Neuroimmune Pharmacol (2012) 0.96
HIV-1 envelope protein gp120 up regulates CCL5 production in astrocytes which can be circumvented by inhibitors of NF-κB pathway. Biochem Biophys Res Commun (2011) 0.90
Expression of HIV gp120 protein increases sensitivity to the rewarding properties of methamphetamine in mice. Addict Biol (2012) 0.82
Interactions of HIV and drugs of abuse: the importance of glia, neural progenitors, and host genetic factors. Int Rev Neurobiol (2014) 0.81
CB2 receptor agonists protect human dopaminergic neurons against damage from HIV-1 gp120. PLoS One (2013) 0.81
Methamphetamine Exposure Combined with HIV-1 Disease or gp120 Expression: Comparison of Learning and Executive Functions in Humans and Mice. Neuropsychopharmacology (2015) 0.81
Increased Sensitivity to Cocaine Self-Administration in HIV-1 Transgenic Rats is Associated with Changes in Striatal Dopamine Transporter Binding. J Neuroimmune Pharmacol (2015) 0.79
A Novel Role of Proline Oxidase in HIV-1 Envelope Glycoprotein-induced Neuronal Autophagy. J Biol Chem (2015) 0.79
Characterization of neuropathology in the HIV-1 transgenic rat at different ages. J Neuroimmunol (2016) 0.78
Calpain-mediated degradation of MDMx/MDM4 contributes to HIV-induced neuronal damage. Mol Cell Neurosci (2013) 0.78
Lack of neuroinflammation in the HIV-1 transgenic rat: an [(18)F]-DPA714 PET imaging study. J Neuroinflammation (2015) 0.78
Central nervous system tuberculosis: pathogenesis and clinical aspects. Clin Microbiol Rev (2008) 2.88
Role of microglia in central nervous system infections. Clin Microbiol Rev (2004) 2.69
Neuropathogenesis of congenital cytomegalovirus infection: disease mechanisms and prospects for intervention. Clin Microbiol Rev (2009) 1.90
Cutting edge: TLR2-mediated proinflammatory cytokine and chemokine production by microglial cells in response to herpes simplex virus. J Immunol (2005) 1.88
Morphine induces apoptosis of human microglia and neurons. Neuropharmacology (2002) 1.61
Globalization: a new dimension for academic internal medicine. Am J Med (2006) 1.50
Synthetic cannabinoid WIN55,212-2 inhibits generation of inflammatory mediators by IL-1beta-stimulated human astrocytes. Glia (2005) 1.49
Prolonged microglial cell activation and lymphocyte infiltration following experimental herpes encephalitis. J Immunol (2008) 1.48
Opioid G protein-coupled receptors: signals at the crossroads of inflammation. Trends Immunol (2003) 1.45
Interleukin-10 attenuates production of HSV-induced inflammatory mediators by human microglia. Glia (2004) 1.26
Toll-like receptors in defense and damage of the central nervous system. J Neuroimmune Pharmacol (2007) 1.24
Microglia as a pharmacological target in infectious and inflammatory diseases of the brain. J Neuroimmune Pharmacol (2006) 1.23
Morphine potentiates HIV-1 gp120-induced neuronal apoptosis. J Infect Dis (2005) 1.20
Microglial cells initiate vigorous yet non-protective immune responses during HSV-1 brain infection. Virus Res (2006) 1.18
Differential responses of human brain cells to West Nile virus infection. J Neurovirol (2005) 1.17
Mycobacterium tuberculosis-induced cytokine and chemokine expression by human microglia and astrocytes: effects of dexamethasone. J Infect Dis (2005) 1.17
TNF-alpha-induced chemokine production and apoptosis in human neural precursor cells. J Leukoc Biol (2005) 1.14
High-level expression of functional chemokine receptor CXCR4 on human neural precursor cells. Brain Res Dev Brain Res (2004) 1.09
Cocaine-induced HIV-1 expression in microglia involves sigma-1 receptors and transforming growth factor-beta1. Int Immunopharmacol (2006) 1.08
CXCL10 production from cytomegalovirus-stimulated microglia is regulated by both human and viral interleukin-10. J Virol (2003) 1.08
Neural precursor cell susceptibility to human cytomegalovirus diverges along glial or neuronal differentiation pathways. J Neurosci Res (2005) 1.07
Reactive oxygen species drive herpes simplex virus (HSV)-1-induced proinflammatory cytokine production by murine microglia. J Neuroinflammation (2011) 1.05
Early detection of central nervous system tuberculosis with the gen-probe nucleic Acid amplification assay: utility in an inner city hospital. Clin Infect Dis (2002) 1.05
Herpes simplex virus induces neural oxidative damage via microglial cell Toll-like receptor-2. J Neuroinflammation (2010) 1.05
Intracerebral infection with murine cytomegalovirus induces CXCL10 and is restricted by adoptive transfer of splenocytes. J Neurovirol (2004) 1.03
Serial testing of refugees for latent tuberculosis using the QuantiFERON-gold in-tube: effects of an antecedent tuberculin skin test. Am J Trop Med Hyg (2009) 1.03
Chronic cortical and subcortical pathology with associated neurological deficits ensuing experimental herpes encephalitis. Brain Pathol (2009) 1.02
Murine cytomegalovirus infection of neural stem cells alters neurogenesis in the developing brain. PLoS One (2011) 1.01
Cocaine alters proliferation, migration, and differentiation of human fetal brain-derived neural precursor cells. J Pharmacol Exp Ther (2006) 1.01
Dysregulated interferon-gamma responses during lethal cytomegalovirus brain infection of IL-10-deficient mice. Virus Res (2007) 1.00
Differential apoptotic signaling in primary glial cells infected with herpes simplex virus 1. J Neurovirol (2006) 0.99
Antimicrobial resistance in Escherichia coli causing urinary tract infections in Costa Rica: a clinical dilemma. Int J Antimicrob Agents (2003) 0.98
WIN55,212-2-mediated inhibition of HIV-1 expression in microglial cells: involvement of cannabinoid receptors. J Neuroimmune Pharmacol (2006) 0.96
Toll-like receptor 2 signaling is a mediator of apoptosis in herpes simplex virus-infected microglia. J Neuroinflammation (2007) 0.96
Memory T cells persisting in the brain following MCMV infection induce long-term microglial activation via interferon-γ. J Neurovirol (2011) 0.95
Microglia are the major cellular source of inducible nitric oxide synthase during experimental herpes encephalitis. J Neurovirol (2008) 0.94
U50,488 inhibits HIV-1 Tat-induced monocyte chemoattractant protein-1 (CCL2) production by human astrocytes. Biochem Pharmacol (2003) 0.93
Morphine stimulates CCL2 production by human neurons. J Neuroinflammation (2006) 0.92
T cell-mediated restriction of intracerebral murine cytomegalovirus infection displays dependence upon perforin but not interferon-gamma. J Neurovirol (2005) 0.91
Kappa-opioid receptor agonist inhibition of HIV-1 envelope glycoprotein-mediated membrane fusion and CXCR4 expression on CD4(+) lymphocytes. Biochem Pharmacol (2002) 0.90
Glial cell responses to herpesvirus infections: role in defense and immunopathogenesis. J Infect Dis (2002) 0.90
Inhibition of toll-like receptor signaling in primary murine microglia. J Neuroimmune Pharmacol (2007) 0.90
Anti-HIV-1 activity of propolis in CD4(+) lymphocyte and microglial cell cultures. J Ethnopharmacol (2005) 0.88
Kappa-opioid receptor ligands inhibit cocaine-induced HIV-1 expression in microglial cells. J Pharmacol Exp Ther (2004) 0.88
Potentiation of HIV-1 expression in microglial cells by nicotine: involvement of transforming growth factor-beta 1. J Neuroimmune Pharmacol (2007) 0.87
Modulation of experimental herpes encephalitis-associated neurotoxicity through sulforaphane treatment. PLoS One (2012) 0.86
Persistent humoral immune responses in the CNS limit recovery of reactivated murine cytomegalovirus. PLoS One (2012) 0.86
Cytomegalovirus-induced sensorineural hearing loss with persistent cochlear inflammation in neonatal mice. J Neurovirol (2011) 0.86
Cytomegalovirus infection and interferon-gamma modulate major histocompatibility complex class I expression on neural stem cells. J Neurovirol (2008) 0.85
T-cell reconstitution during murine acquired immunodeficiency syndrome (MAIDS) produces neuroinflammation and mortality in animals harboring opportunistic viral brain infection. J Neuroinflammation (2013) 0.85
Reduced lymphocyte infiltration during cytomegalovirus brain infection of interleukin-10-deficient mice. J Neurovirol (2009) 0.83
Excess neutrophil infiltration during cytomegalovirus brain infection of interleukin-10-deficient mice. J Neuroimmunol (2010) 0.83
Glial cells suppress postencephalitic CD8+ T lymphocytes through PD-L1. Glia (2014) 0.82
Morphine modulates gammadelta lymphocytes cytolytic activity following BCG vaccination. Brain Behav Immun (2006) 0.82
Reactive oxygen species from human astrocytes induced functional impairment and oxidative damage. Neurochem Res (2013) 0.82
CB2 receptor agonists protect human dopaminergic neurons against damage from HIV-1 gp120. PLoS One (2013) 0.81
Hemin inhibits NO production by IL-1β-stimulated human astrocytes through induction of heme oxygenase-1 and reduction of p38 MAPK activation. J Neuroinflammation (2010) 0.80
Histoplasma capsulatum yeast phase-specific protein Yps3p induces Toll-like receptor 2 signaling. J Neuroinflammation (2008) 0.79
Role of nitric oxide in defense of the central nervous system against Mycobacterium tuberculosis. J Infect Dis (2008) 0.79
Immunomodulatory properties of kappa opioids and synthetic cannabinoids in HIV-1 neuropathogenesis. J Neuroimmune Pharmacol (2011) 0.78
Changes in the NMR metabolic profile of human microglial cells exposed to lipopolysaccharide or morphine. J Neuroimmune Pharmacol (2010) 0.76
Human neural precursor cells express functional kappa-opioid receptors. J Pharmacol Exp Ther (2007) 0.76